GJH:NYE-Strats Trust US Cellular GIC (USD)

COMMON STOCK | Investment Banking & Investment Services |

Last Closing

USD 9.88

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Investment Banking & Investment Services

Symbol Name Price(Change) Market Cap
MGR Affiliated Managers Group Inc

-0.14 (-0.57%)

USD 5.15B
HCXY Hercules Capital Inc

+0.16 (+0.62%)

USD 1.35B
ECCX Eagle Point Credit Company Inc

+0.13 (+0.53%)

USD 0.45B
IPB Merrill Lynch Depositor Inc.

N/A

USD 0.02B
PYT PPLUS Trust Series GSC 2 Pref

+0.21 (+0.88%)

N/A
BNJ Brookfield Finance Inc. 4.50% ..

-0.09 (-0.50%)

N/A
NRUC National Rural Utilities Coope..

+0.02 (+0.08%)

N/A
GJP STRATS SM Trust for Dominion R..

N/A

N/A
GJR Strats SM Trust for Procter & ..

N/A

N/A
JBK Goldman Sachs Capital I Securi..

N/A

N/A

ETFs Containing GJH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Investment Banking & Investment Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.37% 100% F 72% C
Dividend Return 3.75% 25% F 63% D
Total Return 20.13% 100% F 74% C
Trailing 12 Months  
Capital Gain 21.67% 88% B+ 57% F
Dividend Return 7.85% 94% A 83% B
Total Return 29.53% 88% B+ 66% D+
Trailing 5 Years  
Capital Gain -1.24% 60% D- 42% F
Dividend Return 28.68% 82% B 82% B
Total Return 27.44% 80% B- 49% F
Average Annual (5 Year Horizon)  
Capital Gain -1.53% N/A N/A 28% F
Dividend Return 4.83% N/A N/A 47% F
Total Return 6.36% N/A N/A 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 14.06% N/A N/A 67% D+
Risk Adjusted Return 34.40% N/A N/A 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike